Search
Patexia Research
Case number 3:22-cv-05830

NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al > Summary

Court Case Number 3:22-cv-05830

Filing Date Sep 30, 2022

Termination Date Dec 20, 2022

Court New Jersey District Court

Status Dismissed - Voluntarily

JudgesZahid N. Quraishi

Plaintiff

Neurocrine Biosciences

Defendant

4

Zydus Pharmaceuticals

Zydus Worldwide

Zydus Healthcare (USA) LLC

Zydus Lifesciences Limited

Related Patents

Doc No Title Issue date
11311532 High dosage valbenazine formulation and compositions, methods, and kits related thereto Apr 26, 2022
11040029 Methods for the administration of certain VMAT2 inhibitors Jun 22, 2021
11026931 Methods for the administration of certain VMAT2 inhibitors Jun 8, 2021
11026939 High dosage valbenazine formulation and compositions, methods, and kits related thereto Jun 8, 2021
10993941 Methods for the administration of certain VMAT2 inhibitors May 4, 2021
10952997 Methods for the administration of certain VMAT2 inhibitors Mar 23, 2021
10940141 Methods for the administration of certain VMAT2 inhibitors Mar 9, 2021
10919892 Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) Feb 16, 2021
10912771 Methods for the administration of certain VMAT2 inhibitors Feb 9, 2021
10906902 Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) Feb 2, 2021
10906903 Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1,-a]isoquinolin-2-yl 2-amino-3-methylbutanoate di(4-methylbenzenesulfonate) Feb 2, 2021
10874648 Methods for the administration of certain VMAT2 inhibitors Dec 29, 2020
10857137 Methods for the administration of certain VMAT2 inhibitors Dec 8, 2020
10857148 Methods for the administration of certain VMAT2 inhibitors Dec 8, 2020
10851103 Valbenazine salts and polymorphs thereof Dec 1, 2020
10851104 Valbenazine salts and polymorphs thereof Dec 1, 2020
10844058 Valbenazine salts and polymorphs thereof Nov 24, 2020
10065952 Valbenazine salts and polymorphs thereof Sep 4, 2018
Menu